Dr. Reddy's Laboratories Limited (RDY) — Financial statements
Income statement, balance sheet, and cash flow for Dr. Reddy's Laboratories Limited — annual and quarterly history with growth and margin analysis.
| Metric (INR Millions) | 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 353,472↑8.6% | 325,535↑16.6% | 279,164↑13.5% | 245,879↑14.7% | 214,391 | |
| Cost of Revenue | 166,953↑23.6% | 135,107↑16.9% | 115,557↑8.5% | 106,536↑6.0% | 100,551 | |
| Gross Profit | 186,519↓2.1% | 190,428↑16.4% | 163,607↑17.4% | 139,343↑22.4% | 113,840 | |
| Operating Expenses | ||||||
| R&D Expenses | 25,314↓7.5% | 27,380↑19.7% | 22,873↑18.0% | 19,381↑10.9% | 17,482 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 112,337↑19.7% | 93,870↑21.6% | 77,201↑13.5% | 68,026↑9.6% | 62,081 | |
| Other Expenses | 0.00↑100.0% | -2,665↑36.5% | -4,196↑19.4% | -5,208↓208.5% | 4,801 | |
| Operating Expenses | 137,651↑16.1% | 118,585↑23.7% | 95,878↑16.6% | 82,199↓2.6% | 84,364 | |
| Total Costs & Expenses | 304,604↑20.1% | 253,692↑20.0% | 211,435↑12.0% | 188,735↑2.1% | 184,915 | |
| Operating Results | ||||||
| Operating Income | 48,868↓32.0% | 71,843↑6.1% | 67,729↑18.5% | 57,144↑93.9% | 29,476 | |
| Depreciation & Amortization | 21,682↑27.1% | 17,058↑14.9% | 14,841↑17.5% | 12,636↑6.9% | 11,824 | |
| EBITDA | 70,550↓27.0% | 96,671↑9.3% | 88,422↑18.8% | 74,431↑65.1% | 45,080 | |
| EBIT | 48,868↓38.6% | 79,613↑8.2% | 73,581↑19.1% | 61,795↑85.8% | 33,256 | |
| Interest & Other Income | ||||||
| Net Interest Income | 4,348↑2960.3% | -152↓126.8% | 567↑328.6% | -248↓3642.9% | 7 | |
| Interest Income | 8,281↑209.3% | 2,677↑17.5% | 2,278↑93.1% | 1,180↑22.3% | 965 | |
| Interest Expense | 3,933↑39.0% | 2,829↑65.3% | 1,711↑19.8% | 1,428↑49.1% | 958 | |
| Non-Operating Income | 0.00↑100.0% | -7,770↓32.8% | -5,852↓25.8% | -4,651↓23.0% | -3,780 | |
| Other Income / Expenses | 8,811↑78.3% | 4,941↑19.3% | 4,141↑28.5% | 3,223↑14.2% | 2,822 | |
| Income Before Tax | 57,679↓24.9% | 76,784↑6.8% | 71,870↑19.1% | 60,367↑86.9% | 32,298 | |
| Income Tax Expense | 12,996↓33.5% | 19,539↑20.7% | 16,186↑5.8% | 15,300↑75.3% | 8,730 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 44,683↓21.9% | 57,245↑2.8% | 55,684↑23.6% | 45,067↑91.2% | 23,568 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 45,087↓20.3% | 56,544↑1.5% | 55,684↑23.6% | 45,067↑91.2% | 23,568 | |
| Bottom-Line Net Income | 45,087↓20.3% | 56,544↑1.5% | 55,684↑23.6% | 45,067↑91.2% | 23,568 | |
| EPS (Basic) | 53.92↓20.5% | 67.85↑1.6% | 66.80↑23.0% | 54.29↑91.0% | 28.42 | |
| EPS (Diluted) | 53.92↓20.4% | 67.77↑1.5% | 66.80↑23.3% | 54.17↑91.1% | 28.34 | |
| Weighted Average Shares | 832↓0.1% | 833↓0.0% | 834↑0.4% | 830↑0.1% | 829 | |
| Weighted Average Diluted Shares | 833↓0.1% | 834↑0.1% | 834↑0.2% | 832↑0.0% | 832 | |
* All figures in Millions of INR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.